Nucleome Therapeutics appoints Nigel Clark as Chief Business Officer
Nucleome Therapeutics appoints Nigel Clark as Chief Business Officer Nigel brings 20+ years of commercial and senior managerial experience in the biotech and pharma industry Oxford, UK